Despite the proven benefits of anti-VEGF injections for patients with retinal vein occlusion, a retrospective review of billing codes showed one in four patients lost to follow-up after receiving an intravitreal injection.
Until recently, the follow-up rates of patients receiving anti-VEGF injections for retinal vein occlusion (RVO) were not considered, Jason Hsu, MD, study co-author, told Ocular Surgery News.
“These injections have proven benefits but often require ongoing monitoring and treatment. Our finding that about a quarter of patients with retinal vein occlusions who receive an
Uncategorized